ustekinumab,vedolizumab
takeda,janssen
['vedo', 'crohn', ' vedo', 'vedolizumab', 'ustekinumab']
the evolve expansion study real-world clinical effectiveness of vdz vs ust in bio na ve cd presented by marc ferrante #ddw2023 #agalive 
Celebrate life. Gastroenterologist #IBD passionate. Help others grow their abilities. https://t.co/4V0xhhdIti